medigraphic.com
ISSN 1561-3046 (Electronic)

2015, Number 2

<< Back Next >>

Rev Cub Med Mil 2015; 44 (2)

Severity index involvement in tinea pedis

Pérez BM, Falcón LL, Miranda GO, Torres Lio-Coo V, Velázquez PA, Rodríguez PY

Language: Spanish
References: 20
Page: 161-169
PDF size: 219.12 Kb.


ABSTRACT

Introduction: tinea pedis is a dermatophyte infection that affects feet and areas between toes, it often invades edges, sides and plants, it has a high incidence, tendency to relapse and rebellious to treatment.
Objective: assess the severity of flaky tinea pedis through the rate of severity and impairment of tinea pedis (ISATP).
Methods: an assessment study was conducted in 347 patients who were diagnosed with flaky tinea pedis. They were assisted in Dermatology services at Military Central Hospital, from September 2010 to September 2012. The ISATP algorithm was applied. It was developed from psoriasis area and severity rate (PASI).
Results: moderate ISATP prevailed (46.6 %). It was most frequently found in the age group of 46-55 years (55.9 %), and in males (73.1 %). Depending on the color of skin, white patients (40.0 %) had the highest frequency. Severe ISATP prevailed in the age group of 56-65 years (50.0 %) in males (93.5 %) and in patients with black skin color (65.7 %).
Conclusions: the algorithm used, ISATP, is useful to define the degree of severity of squamous tinea pedis in patients as mild, moderate and severe; also, it allows defining variables relate to age, sex and skin color.


REFERENCES

  1. Mycoses and Modernity. Basingstoke (UK): Palgrave Macmillan; 2013. p. 20-40.

  2. Bristow IR, Borthwick AM. Dermatology within the UK pediatric literature: a content analysis (1989-2010). J Foot Ankle Res. 2013;6:2-15.

  3. Somchit MN, Adam Y, Yee HC, Zuraini A, Arifah AK, Zakaria ZA. Anti-fungal activity of Ardisiacrispa(Thunb.) A.DC. against several fungi responsible for athlete's foot African. J Microbiol Res. 2011 Aug;5(15):2008-10.

  4. Pérez Bruzón M, Batista Romagoza M, López Osorio D, Siam Alonso N, Raventós Vázquez AM. Consideraciones actualizadas sobre la patogenia de la tiña pedis. MEDISAN. 2010;14(1):103.

  5. Bell-Syer SEM, Khan SM, Torgerson DJ. Oral treatments for fungal infections of the skin of the foot. Cochrane Database of Systematic Reviews. 2012 [cited 2013 Jul 17];(10). Available from: http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD003584.pub2/pdf

  6. Mishimoto K. The control of dermatophytoses base on ecological aspect of causative fungi. Nippon Ishinkin Gakkai Zasshi. 2009;50(1):10-6.

  7. Hay RJ. Bacteria and foot infections. J Eur Acad Dermatol Venereol. 2004;18(Suppl):120-2.

  8. Valdivia Blondet L. Las dermatofitosis: clínica, diagnóstico y tratamiento. Dermatol Perú. 2005;13(1):7-12.

  9. Jones P. Enfermedades de la piel; diagnóstico y tratamiento. Madrid: Editorial Elsever; 2008.

  10. Falcón Lincheta L, Daniel Simón R, Menéndez Cepero S, Landa Díaz N, Moya Duque S. Solución para la epidermofitosis de los pies en integrantes de las Fuerzas Armadas Revolucionarias. Rev Cubana Med Mil [Internet]. 2000 May-Ago [citado 3 jul 2013];29(2):[aprox. 9 p.]. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0138-65572000000200004

  11. Cruz CR, Ponce EE, Calderón RL, Delgado VN, Vieille OP, Piontelly LE. Micosis superficiales en ciudad de Valparaíso, Chile. Período 2007-2009. Rev Chil Infect. 2011;28(5):404-9.

  12. Somchit MN, Adam Y, Yee HC, Zuraini A, Arifah AK, Zakaria ZA. Anti-fungal activity of Ardisiacrispa(Thunb.) A.DC. against several fungi responsible for athlete's foot. African J Microbiol Research. 2011 Aug;5(15):2008-10.

  13. Braun-Falco O, Plewig G, Wolff HH, Burgdorf WHC. Dermatology. 2da ed. Berlin: Springer; 2000.

  14. Beikert FC, Anastasiadou Z, Fritzen B, Frank U, Augustin M. Topical treatment of tinea pedis using 6 % coriander oil in unguentum leniens: a randomized, controlled, comparative pilot study. Dermatology. 2013 May;226(1):47-51.

  15. Wolkerstorfer A, Dewaard Van Der Spek FB, Glazenburg EJ, Mulder H PG, Oranje AP.Scoring the severity of Atopic dermatitis. ActaDermVenereol. 1999;79:356-59.

  16. Gutiérrez Ylave Z. Evaluación del índice de severidad y área de psoriasis (PASI), en 157 pacientes del club de psoriasis del servicio de dermatología del Hospital Nacional Daniel Alcides Carrión. DermatolPeru[Internet]. 2003 Sep-Dic [citado 3 jul 2013];13(3):[aprox. 12 p.]. Disponible en: http://revistas.concytec.gob.pe/scielo.php?pid=S1028- 71752003000300004&script=sci_arttext

  17. Cohen AD, Wolak A, Alkan M, Shalev R, Ardy DA. AFSS. Athlete´s foot severity score. A proposal and validation. Rev Mycoses. 2002;45:97-100.

  18. Koga H, Nanjoh Y, Kaneda H, Yamaguchi H, Tsuboic R. Short-Term Therapy with Luliconazole, a novel topical antifungalimidazole, in guinea pig model soft tinea corporisand tinea pedis. Antimicrobial Agents Chemotherapy. 2012 Jun;56(6):3138-43.

  19. Matricciani L, Talbot K, Jones S. Safety and efficacy of tineapedis and Onychomycosis treatment in people with diabetes: a systematic review. J Foot Ankle Res. 2011;4(26):2-12.

  20. Carrillo-Muñoz AJ, Tur-Tur C, Cárdenes DC, Estivill D, Giusiano G. Sertaconazole nitrate shows fungicidal and fungistatic activities against Trichophy tonrubrum, Trichophy tonmentagrophytes, and Epidermophy tonfloccosum, causative agents of tineapedis. Antimicrobial Agents Chemotherapy. 2011 Sept;55(9):4420-2.




2020     |     www.medigraphic.com